122 related articles for article (PubMed ID: 33853757)
21. The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.
Asteria CR; Pucciarelli S; Gerard L; Mantovani N; Pagani M; Boccia L; Ricci P; Troiano L; Lucchini G; Pulica C
Int J Colorectal Dis; 2015 Dec; 30(12):1627-37. PubMed ID: 26255258
[TBL] [Abstract][Full Text] [Related]
22. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
[TBL] [Abstract][Full Text] [Related]
23. Effects of screening and universal healthcare on long-term colorectal cancer mortality.
Lee YC; Hsu CY; Chen SL; Yen AM; Chiu SY; Fann JC; Chuang SL; Hsu WF; Chiang TH; Chiu HM; Wu MS; Chen HH
Int J Epidemiol; 2019 Apr; 48(2):538-548. PubMed ID: 30184208
[TBL] [Abstract][Full Text] [Related]
24. A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study.
Mansouri D; McMillan DC; McIlveen E; Crighton EM; Morrison DS; Horgan PG
Colorectal Dis; 2016 Oct; 18(10):967-975. PubMed ID: 26859503
[TBL] [Abstract][Full Text] [Related]
25. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
26. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
[TBL] [Abstract][Full Text] [Related]
27. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
28. Management of T1 colorectal cancers detected at screening colonoscopy: A study from the French national screening programme.
Grainville T; Bretagne JF; Piette C; Rousseau C; Bordet M; Cosson M; Lièvre A
Dig Liver Dis; 2020 Aug; 52(8):909-917. PubMed ID: 32505572
[TBL] [Abstract][Full Text] [Related]
29. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
30. Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.
Wieten E; Schreuders EH; Grobbee EJ; Nieboer D; Bramer WM; Lansdorp-Vogelaar I; Bruno MJ; Kuipers EJ; Spaander MCW
Gut; 2019 May; 68(5):873-881. PubMed ID: 29934436
[TBL] [Abstract][Full Text] [Related]
31. Less Invasive Primary Treatment for Colorectal Cancer After Implementation of National Screening: A Nationwide Cohort Study.
Dressler J; Njor SH; Jørgensen LN; Rasmussen M
World J Surg; 2023 Nov; 47(11):2877-2887. PubMed ID: 37610467
[TBL] [Abstract][Full Text] [Related]
32. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.
Levin TR; Corley DA; Jensen CD; Schottinger JE; Quinn VP; Zauber AG; Lee JK; Zhao WK; Udaltsova N; Ghai NR; Lee AT; Quesenberry CP; Fireman BH; Doubeni CA
Gastroenterology; 2018 Nov; 155(5):1383-1391.e5. PubMed ID: 30031768
[TBL] [Abstract][Full Text] [Related]
33. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
[TBL] [Abstract][Full Text] [Related]
34. Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy.
Giorgi Rossi P; Carretta E; Mangone L; Baracco S; Serraino D; Zorzi M;
J Med Screen; 2018 Mar; 25(1):32-39. PubMed ID: 28195508
[TBL] [Abstract][Full Text] [Related]
35. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
36. Initial Impact of National CRC Screening on Incidence and Advanced Colorectal Cancer.
Krul MF; Elferink MAG; Kok NFM; Dekker E; Lansdorp-Vogelaar I; Meijer GA; Nagtegaal ID; Breekveldt ECH; Ruers TJM; van Leerdam ME; Kuhlmann KFD
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):797-807.e3. PubMed ID: 36116753
[TBL] [Abstract][Full Text] [Related]
37. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program.
Chiu HM; Chen SL; Yen AM; Chiu SY; Fann JC; Lee YC; Pan SL; Wu MS; Liao CS; Chen HH; Koong SL; Chiou ST
Cancer; 2015 Sep; 121(18):3221-9. PubMed ID: 25995082
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area.
Cariou M; El Fettouhi A; Kermarrec T; Bommelaere F; Foll Y; Nousbaum JB; Robaszkiewicz M; Quénéhervé L
Cancer Epidemiol; 2020 Dec; 69():101839. PubMed ID: 33096500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
